CHR-6494 TFA [1458630-17-5]

Cat# T9521-2mg

Size : 2mg

Brand : TargetMol


CHR-6494 TFA

Catalog No. T9521   CAS 1458630-17-5

CHR-6494 TFA is a potent haspin inhibitor, with an IC50 of 2 nM. It inhibits histone H3T3 phosphorylation. CHR-6494 TFA induces the apoptosis of cancer cells, including melanoma and breast cancer. CHR-6494 TFA can be used in the research of cancer

All TargetMol products are for research or drug registration purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose in violation of laws and regulations.
CHR-6494 TFA Chemical Structure
CHR-6494 TFA, CAS 1458630-17-5
Description CHR-6494 TFA is a potent haspin inhibitor, with an IC50 of 2 nM. It inhibits histone H3T3 phosphorylation. CHR-6494 TFA induces the apoptosis of cancer cells, including melanoma and breast cancer. CHR-6494 TFA can be used in the research of cancer
Targets&IC50 Haspin:2 nM (IC50)
In vitro Administration of CHR-6494 (TFA; 0-10-5?nM; 72 hours) dose-dependently inhibits the growth of cancer cells, such as HCT-116, HeLa, MDA-MB-231, and Wi-38 cells, with an IC50s of 500?nM, 473?nM, 752?nM and 1059 nM, respectively[1]. Administration of CHR-6494 (TFA; 500 nM) produces a mitotic catastrophe with abnormal morphology of the mitotic spindle and centrosome amplification, and upregulates the spindle assembly checkpoint protein BUB1 and the marker of mitotic arrest cyclin B1[1].
In vivo Administration of CHR-6494 (TFA; 50?mg/kg; i.p. in two cycles of five consecutive days for 15 days) inhibits the growth of tumor and no obvious body weight change is observed in nude mice bearing HCT-116 human colorectal cancer cells[1].
Molecular Weight 406.36
Formula C18H17F3N6O2
CAS No. 1458630-17-5

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

DMSO: 55 mg/mL (135.35 mM)

TargetMolReferences and Literature

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

CHR-6494 TFA 1458630-17-5 Others CHR-6494 inhibit apoptosis Haspin Kinase NRAS mutant melanoma cells CHR 6494 mitotic catastrophe Inhibitor mice CHR6494 cancer cells CHR6494 TFA BRAFV600E mutant melanoma cells CHR 6494 TFA inhibitor